Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
National Journal of Andrology ; (12): 494-498, 2005.
Article in Chinese | WPRIM | ID: wpr-323326

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the correlation of male infertility with abnormality of chromosomal quantity and construction and with the deletion of DAZ gene copy in the AZFc region of Y chromosome.</p><p><b>METHODS</b>Included in the study were 247 azoospermic and 206 severe oligozoospermic patients, as well as 210 fertile men as controls. Multi-PCR and PCR-RFLP were used to analyze the deletion of DAZ gene copies in the AZFc region of Y chromosome. Chromosomal quantity and construction were detected by G-band in the 453 patients.</p><p><b>RESULTS</b>In the azoospermic and severe oligozoospermic patients, the incidences of chromosomal abnormality were 12.6% and 8.3%; the rates of complete DAZ deletion were 7.7% and 11.2%, and the rates of DAZ1/DAZ2 deletion were 7.3% and 4.9% respectively, but no deletion was detected in the controls.</p><p><b>CONCLUSION</b>There is a high frequency of chromosomal abnormality and DAZ gene copy deletion in patients with azoospermia and oligospermia, which suggests that chromosomal abnormality and partial and complete deletion of DAZ gene copy might be important genetic causes of Chinese male infertility.</p>


Subject(s)
Humans , Male , China , Epidemiology , Chromosome Deletion , Chromosomes, Human, Y , Genetics , Deleted in Azoospermia 1 Protein , Gene Dosage , Infertility, Male , Epidemiology , Genetics , Oligospermia , Epidemiology , Genetics , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , RNA-Binding Proteins , Genetics , Sex Chromosome Aberrations
2.
National Journal of Andrology ; (12): 266-269, 2003.
Article in Chinese | WPRIM | ID: wpr-238049

ABSTRACT

<p><b>OBJECTIVES</b>To evaluate the efficacy and safety of sildenafil citrate in the treatment of premature ejaculation (PE) complicated by erectile dysfunction (ED).</p><p><b>METHODS</b>Forty-five patients of PE complicated by ED received flexible doses of sildenafil from 50 to 100 mg for 1 to 3 months. Intravaginal ejaculatory latency time (IELT) and sexual satisfaction ratio (SSR) of partner were recorded to evaluate the effect of PE treatment, as well as the general efficacy and satisfaction of ED treatment. And the difference of IIEF-5 before and after the treatment were compared.</p><p><b>RESULTS</b>Twenty-seven patients had their PE improved and the effective rate was 60%. Forty patients reported the improvement in erection and the percentage of erectile improvement was 88.88%. All the 27 patients with improvement of PE achieved effective erection through the administration of 50 mg sildenafil and the satisfaction rate reached 81.48%. On the other hand, only 1 case (5.56%) reported satisfaction over the treatment in the 18 patients who did not obtain improvement of PE. Between the PE improvement group and non-improvement group, there were significant differences (P < 0.001) shown in IIEF-5 scores before and after the treatment. Mild or moderate side effects were reported in 9 patients(20%), who recovered without any treatment.</p><p><b>CONCLUSIONS</b>To premature ejaculation patients with ED, sildenafil can safely and effectively improve their erectile function, the satisfaction over the ED treatment outcome means that their PE symptoms could be alleviated.</p>


Subject(s)
Adult , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Ejaculation , Erectile Dysfunction , Drug Therapy , Piperazines , Therapeutic Uses , Purines , Sexual Dysfunction, Physiological , Drug Therapy , Sildenafil Citrate , Sulfones , Treatment Outcome , Vasodilator Agents , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL